These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688 [TBL] [Abstract][Full Text] [Related]
6. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD. Zemel D; Betjes MG; Dinkla C; Struijk DG; Krediet RT Perit Dial Int; 1995; 15(2):134-41. PubMed ID: 7612733 [TBL] [Abstract][Full Text] [Related]
7. Gene expression and release of interleukin-8 by peritoneal macrophages and polymorphonuclear leukocytes during peritonitis in uremic patients on continuous ambulatory peritoneal dialysis. Lin CY; Huang TP Nephron; 1994; 68(4):437-41. PubMed ID: 7870228 [TBL] [Abstract][Full Text] [Related]
8. Cytokine networks in continuous ambulatory peritoneal dialysis: interactions of resident cells during inflammation in the peritoneal cavity. Topley N; Mackenzie R; Jörres A; Coles GA; Davies M; Williams JD Perit Dial Int; 1993; 13 Suppl 2():S282-5. PubMed ID: 8399589 [No Abstract] [Full Text] [Related]
9. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Topley N; Williams JD Kidney Int Suppl; 1994 Dec; 48():S71-8. PubMed ID: 7700045 [No Abstract] [Full Text] [Related]
10. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship. Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effect of uremia on peritoneal permeability in an experimental model of continuous ambulatory peritoneal dialysis in anephric rats. Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Breborowicz A; Oreopoulos D Adv Perit Dial; 1999; 15():32-5. PubMed ID: 10682068 [TBL] [Abstract][Full Text] [Related]
12. Regulation of apoptosis by lethal cytokines in human mesothelial cells. Catalan MP; Subirá D; Reyero A; Selgas R; Ortiz-Gonzalez A; Egido J; Ortiz A Kidney Int; 2003 Jul; 64(1):321-30. PubMed ID: 12787425 [TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis. Rashid G; Korzets Z; Bernheim J Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750 [TBL] [Abstract][Full Text] [Related]
14. Variations of cytokine levels and production in CAPD patients. Serre AF; Marie C; Beaujon G; Betail G; Cavaillon JM; Deteix P Int J Artif Organs; 1997 Nov; 20(11):614-21. PubMed ID: 9464871 [TBL] [Abstract][Full Text] [Related]
15. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis. Lin CY; Lin CC; Huang TP Nephron; 1993; 63(4):404-8. PubMed ID: 8459875 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism. McGregor SJ; Topley N; Jörres A; Speekenbrink AB; Gordon A; Gahl GM; Junor BJ; Briggs JD; Brock JH Kidney Int; 1996 Feb; 49(2):525-33. PubMed ID: 8821840 [TBL] [Abstract][Full Text] [Related]
17. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis. Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal change in peritoneal membrane function with continuous ambulatory peritoneal dialysis (CAPD) after peritonitis episodes. Chen JB; Pan HH; Lee CH; Chien YS; Lee CT; Liu TT; Lam KK; Hsu KT Chang Gung Med J; 2004 Jan; 27(1):29-34. PubMed ID: 15074887 [TBL] [Abstract][Full Text] [Related]
19. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumour necrosis factor during peritonitis. Fieren MW; van den Bemd GJ; Bonta IL; Ben-Efraim S J Clin Lab Immunol; 1991 Jan; 34(1):1-9. PubMed ID: 1667936 [TBL] [Abstract][Full Text] [Related]
20. MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages. Sach M; Loetscher P; Burger JA; Knopf HP; Schollmeyer P; Dobos GJ Adv Perit Dial; 1995; 11():19-23. PubMed ID: 8534702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]